Home › Metastatic Cancer › Illinois › Naperville
Metastatic Cancer clinical trials in Naperville, IL
4 studies for Metastatic Cancer are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Northwestern Medicine Cancer Center Warrenville, Warrenville · 3 mi away
- Advocate Good Samaritan Hospital, Downers Grove · 7 mi away
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- Accellacare of Duly, Lisle · 4 mi away
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Accellacare of Duly, Lisle · 4 mi away
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- Edward Cancer Center, Naperville
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer13 studies
- Heart Failure13 studies
- Prostate Cancer10 studies
- Breast Cancer9 studies
- Cardiovascular Disease8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Geographic Atrophy6 studies
- Macular Degeneration6 studies
- Pancreatic Cancer6 studies
- Cancer (all types)5 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.